Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

NCT00974818 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Bladder Cancer

Interventions

DRUG: Mitomycin C (MMC)
BIOLOGICAL: Bacillus Calmette-Guerin (BCG)

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]